Sudarshan Pharma Industries (BOM:543828) EV-to-EBIT : 23.43 (As of Jun. 01, 2025)

Sudarshan Pharma Industries EV-to-EBIT Chart

Sudarshan Pharma Industries Annual Data
	Trend	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24	Mar25
EV-to-EBIT		Get a 7-Day Free Trial				-	-	11.13	11.71	24.16

Sudarshan Pharma Industries Semi-Annual Data
	Mar17	Mar18	Mar19	Mar20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
EV-to-EBIT	Get a 7-Day Free Trial								11.13	-	11.71	-	24.16

Competitive Comparison of Sudarshan Pharma Industries's EV-to-EBIT

For the Chemicals subindustry, Sudarshan Pharma Industries's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sudarshan Pharma Industries's EV-to-EBIT Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sudarshan Pharma Industries's EV-to-EBIT falls into.

Sudarshan Pharma Industries EV-to-EBIT Calculation

Sudarshan Pharma Industries's EV-to-EBIT for today is calculated as:

Sudarshan Pharma Industries's current Enterprise Value is ₹8,762 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sudarshan Pharma Industries's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹374 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries  (BOM:543828) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Sudarshan Pharma Industries's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2025 is calculated as:

Sudarshan Pharma Industries's Enterprise Value for the quarter that ended in Mar. 2025 was ₹9,037 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sudarshan Pharma Industries's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was ₹374 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Sudarshan Pharma Industries's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Sudarshan Pharma Industries Business Description